Postmenopausal low estradiol, blunted cortisol restraint, and inflammatory cytokines can reinforce inflammatory ferritin elevation

Molecular Mechanisms of the Triad: Estradiol, Cortisol, and Cytokines

The physiological transition into postmenopause is characterized by a profound decline in ovarian 17β-estradiol, which normally functions as a potent modulator of immune homeostasis.

• Loss of Estrogen's Anti-inflammatory Brake: Estradiol historically suppresses the transcription of major pro-inflammatory cytokines—specifically interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-$\alpha$), and interleukin-1 beta (IL-1$\beta$)—by inhibiting nuclear factor kappa B (NF-κB) signaling. With the postmenopausal drop in estradiol, this inhibitory brake is lost, initiating a shift toward a chronic, low-grade inflammatory state.
• The Glucocorticoid Receptor-Cytokine Feedback Loop: Under homeostatic conditions, cortisol acts via the glucocorticoid receptor (GR-$\alpha$) to suppress inflammation. However, sustained elevations of pro-inflammatory cytokines (such as IL-6 and TNF-$\alpha$) actively disrupt this pathway. They induce the expression of the dominant-negative glucocorticoid receptor beta (GR-$\beta$) isoform and impair the nuclear translocation of GR-$\alpha$. This molecular resistance blunts the tissue-level anti-inflammatory "restraint" of cortisol, allowing runaway cytokine production to continue unimpeded, which further perpetuates GR resistance.

Pathophysiology of Inflammatory Ferritin Elevation

The intersection of low-grade immune activation and hormonal shifts directly alters iron homeostasis, driving up serum ferritin without an increase in total body iron stores.

• Cytokine-Induced Ferritin Synthesis: Ferritin is a well-established positive acute-phase reactant. Pro-inflammatory cytokines directly upregulate the translation of ferritin L- and H-chains in hepatocytes and macrophages, independent of systemic iron levels.
• The Hepcidin-Ferroportin Axis: Inflammatory cytokines (particularly IL-6) bind to their receptors on hepatocytes, activating the JAK/STAT3 signaling pathway to upregulate the transcription of HAMP (the gene encoding hepcidin). Simultaneously, the loss of postmenopausal estradiol removes an additional transcriptional brake, as estradiol normally suppresses hepcidin expression through estrogen receptor-alpha (ER$\alpha$) binding to the HAMP promoter.
• Intracellular Iron Sequestration: Elevated circulating hepcidin binds to and triggers the internalization and degradation of the sole cellular iron exporter, ferroportin, on macrophages and duodenal enterocytes. This traps iron inside reticuloendothelial cells, stimulating the intracellular synthesis of ferritin to safely store the sequestered iron, resulting in elevated serum ferritin levels.

Clinical Implications

• Distinguishing Inflammation from Iron Overload: In postmenopausal patients presenting with elevated ferritin, clinicians should evaluate markers of systemic inflammation (such as high-sensitivity C-reactive protein [hs-CRP]) and assess transferrin saturation. An elevated ferritin level paired with normal or low transferrin saturation strongly suggests an inflammatory etiology (anemia of chronic disease/ferritinemia) driven by this neuroendocrine-immune loop, rather than true hemochromatosis.
• Therapeutic Targets: Addressing this triad requires a multi-pronged approach that goes beyond simple iron restriction (which can worsen anemia in these cases). Interventions should focus on dampening the inflammatory cascade, supporting HPA-axis resilience to restore cortisol sensitivity, and, where appropriate, considering hormone replacement therapy (HRT) to restore the homeostatic, anti-inflammatory benefits of estradiol.

Bottom Line

Postmenopausal estradiol depletion, blunted cortisol sensitivity, and chronic cytokine production form a self-reinforcing, pathogenic loop. This triad drives sustained, low-grade systemic inflammation and upregulates the hepcidin-ferroportin axis, culminating in elevated serum ferritin through both acute-phase protein synthesis and intracellular iron sequestration.